Interview: Greg Fischer: SBM at Eaze
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Two weeks of headlines confirm a market sorting itself by balance sheet rather than by ambition. Cannabis is consolidating into a smaller circle of disciplined operators, while psychedelics graduate from pilot programs ...
Virginia Lawmakers Send Cannabis Retail Framework to Governor’s Desk
RICHMOND – The Virginia General Assembly approved budget language that sets the terms for a regulated adult-use Сannabis market, sending the measure to Gov. Abigail Spanberger after a year of stalled bills and one rejected ...
Definium Clears Phase 3 Trial for its LSD-Based Depression Treatment
NEW YORK – Definium Therapeutics Inc. announced positive topline data from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet (ODT) formulation of pharmaceutical LSD, in adults with major depressive disorder (MDD). The ...
